Prediabetes Twist: One Year, 20-Year Ripple

Person using a blood glucose meter to check their levels

A 21-year study just proved that changing how you eat and move can protect you from a cascade of chronic diseases — and a popular diabetes drug cannot.

Story Snapshot

Adults with prediabetes who made intensive lifestyle changes had a 21% lower risk of developing two or more chronic conditions over 20 years compared to a placebo group.
The drug metformin showed no meaningful reduction in that same multimorbidity risk — lifestyle change was the clear winner.
The benefit held even when diabetes was removed from the equation, meaning lifestyle changes protected against a wide range of other diseases too.
Despite preventing diabetes, neither lifestyle changes nor metformin reduced major heart attacks or strokes over 21 years — a critical nuance the headlines often miss.

The Longest Look Yet at What Lifestyle Change Actually Does

The Diabetes Prevention Program (DPP) is one of the most important health studies ever run in the United States. It started in the late 1990s and enrolled over 3,200 adults who all had prediabetes — meaning their blood sugar was high but not yet in the diabetic range. Researchers split them into three groups: one took a placebo, one took the drug metformin, and one made real lifestyle changes focused on modest weight loss and more physical activity. The results from those first three years were striking. Lifestyle change cut the risk of developing type 2 diabetes by 58%. Metformin cut it by 31%.^[2]

What 21 Years of Follow-Up Revealed About Chronic Disease

Researchers kept tracking those same participants for two more decades. A new analysis published in JAMA in June 2026 asked a bigger question: did the lifestyle group end up with fewer chronic diseases overall — not just less diabetes? The answer was yes. Participants who made lifestyle changes had a 21% lower risk of developing multimorbidity, which means having two or more chronic conditions at the same time. That risk reduction held up even when researchers removed diabetes from the list entirely.^[1] That last part matters. It tells us the benefit was not just about preventing one disease.

The study tracked 15 chronic conditions pulled from Medicare records, including heart disease, stroke, chronic kidney disease, chronic obstructive pulmonary disease, cancer, depression, dementia, and arthritis. Eighty-five percent of all participants developed at least two of these conditions during the follow-up period. That number alone tells you how common and serious multimorbidity is among aging Americans.^[13] For the costliest disease combinations — pairs involving stroke, kidney disease, heart failure, and lung disease — the lifestyle group had a 43% lower risk compared to the placebo group.^[1]

The Metformin Finding That Doctors Need to Hear

Metformin is one of the most prescribed drugs in the world. Millions of Americans with prediabetes or early type 2 diabetes take it every day. So the DPP findings on metformin deserve honest attention. After 21 years, metformin did not produce a statistically meaningful reduction in multimorbidity risk compared to placebo.^[1] It also did not reduce major cardiovascular events like heart attacks or strokes.^[6] The drug did delay diabetes development by about 2.5 years, which is real value. But the data make clear that a pill is not a substitute for changing how you live.

The Honest Limits of What This Data Shows

The science here is strong, but it is not without limits. The same long-term follow-up data also shows that neither the lifestyle intervention nor metformin reduced major cardiovascular events over 21 years — despite both groups having less diabetes.^[6] That is a humbling finding. Preventing diabetes did not automatically prevent heart attacks. The lifestyle group’s advantage in multimorbidity is real, but it is measured as a composite burden of illness, not a single hard endpoint like surviving a heart attack.^[8] Honest science requires saying both things out loud.

NIH: For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions.
Over 20+ years, researchers found no significant difference in risk reduction between metformin and a placebo.

Full study: https://t.co/POUvtyXC9m @BethFratesMD

— Dr. Eddie Ramirez (@EddieRDMD) June 16, 2026

What the data does show clearly is that the benefits of short-term lifestyle change can echo for decades. Participants who went through the intensive program between 1996 and 1999 were still showing lower disease rates 20 years later.^[5] That is a remarkable return on a relatively modest investment — losing around 7% of body weight and walking briskly for 150 minutes a week. No drug has ever matched that durability. The effects of medications faded when people stopped taking them. The effects of lifestyle change did not.^[12]

What This Means If You Are Over 40 With Prediabetes

About 98 million American adults have prediabetes, and most do not know it. The DPP data makes a strong case that the window between normal blood sugar and a type 2 diabetes diagnosis is not just a warning — it is an opportunity. Acting during that window with real lifestyle change, not just a prescription, appears to shift the entire trajectory of how your body ages. The lifestyle group gained roughly 3.5 extra years without diabetes compared to the placebo group.^[5] More importantly, they ended up with fewer diseases piling on top of each other as they aged.

The takeaway from 21 years of data is not complicated. Eat better, move more, lose a modest amount of weight, and do it before diabetes arrives. The science says those actions leave a biological fingerprint that lasts for decades. That is not a wellness cliche. That is one of the most well-documented findings in modern preventive medicine.